Vascular endothelial growth factor (VEGF) in astrocytic gliomas - A prognostic factor?

Journal of Neuro-Oncology

Volumn 45, Issue 2, 1999, Pages 117-125

  Oehring, Randi D ^a   Miletic, Melitta ^a   Valter, Markus M ^a   Pietsch, Torsten ^a   Neumann, Jürgen ^a   Fimmers, Rolf ^a   Schlegel, Uwe ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Astrocytic glioma; Immunohistochemistry; Prognosis; Vascular endothelial growth factor (VEGF)

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; ASTROCYTE; ASTROCYTOMA; BRAIN TISSUE; CANCER GRADING; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL TIME; TUMOR GROWTH;

ADULT; ASTROCYTOMA; BLOTTING, WESTERN; BRAIN NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033499079     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006333005563     Document Type: Article

References (43)

1. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumors of the Central Nervous System. 2nd ed., Springer Verlag, Berlin, 1993
2. Shaw EG, Daumas-Duport C, Scheithauer BW: Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 70: 853-861, 1989
3. Vertosick FT, Selker RG, Arena VC: Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography. J Neurosurg 28: 496-501, 1991
4. Kreth FWM, Faist M, Warnke PC: Interstitial radiosurgery of low-grade gliomas. J Neurosurg 82: 418-429, 1995
5. Waha A, Baumann A, Wolf HK, Fimmers R, Neumann J, Kindermann D, Astrahantseff K, Blümcke I, von Deimling A, Schlegel U: Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-α pathway in human astrocytic gliomas. J Neurosurg 85: 634-641, 1996
6. Plate KH, Mennel HD: Vascular morphology and angiogenesis in glial tumors. Exp Toxic Pathol 47: 89-94, 1995
7. Quinn TP, Peters KG, de Vries C, Ferrara N, Williams LT: Fetal liver kinase 1 is a receptor for a vascular endothelial growth factors and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90: 7533-7537, 1990
8. Jakemann LB, Winer J, Benett GL, Altar CA, Ferrara N: Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89: 244-253, 1992
9. Ullrich A, Schlesinger J: Signal transduction by receptors with tyrosine kinase activity Cell 61: 203-212, 1990
10. Goldman CK, Kim J, Wong WL, King V, Brock T, Gillespie GY: Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 4: 121-133, 1993
11. Tsai JC, Goldmann CK, Gillepie GY: Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB and bFGF. J Neurosurg 82: 864-873, 1995
12. Valter MM, Wiestler OD, Pietsch T: Differential control of VEGF synthesis and secretion in human glioma cells by IL-1 and EGF. Int J Dev Neurosci 1999 (in press)
13. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844, 1993
14. Millauer B, Shawyer LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant negative FLK-1 mutant. Nature 367: 576-579, 1994
15. Saleh M, Stacker SA, Wilks AF: Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56(2): 393-401, 1996
16. Cheng SY, Huang HJS, Nagane M, Ji XD, Wang D, Shih CCY, Arap W, Huang CM, Cavenee WK. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci USA 93: 8502-8507, 1996
17. Rosen LS, Kabbinavar F, Rosen P, Mulay M, Quigley S, Hannah AL: Phase 1 trial of SU5416, a novel angiogenesis inhibitor in patients with advanced malignancies. (Abstract). In: Angiogenesis and Cancer. Jan 1998, Orlando, USA
18. Plate KH, Warnke PC: Vascular endothelial growth factor. J Neuro-Oncol 35: 365-372, 1997
19. Plate KH, Risau W: Angiogenesis in malignant gliomas. Glia 15: 339-347, 1995
20. Zagzag D: Angiogenic growth factors in neural embryogenesis and neoplasia. Am J Pathol 146: 293-309, 1995
21. Pietsch T, Valter MM, Wolf HK, von Deimling A, Huang HJS, Cavenee WK, Wiestler OD: Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 93: 109-117, 1997
22. Nishikawa R, Cheng SY, Nagashima R, Huang HJS, Cavenee WK, Matsutani M: Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol 96: 453-462, 1998
23. Plate HK, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359 (6398): 845-848, 1992
24. Schlegel U, Moots PL, Rosenblum MK, Furneaux H: Expression of transforming growth factor alpha in human gliomas. Oncogene 5: 1839-1842, 1990
25. Cordell JL, Falini B, Erber WN, Gosh AK, Abdulaziz Z, Macdonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219-229, 1984
26. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. Wiley & Sons, New York, 1980
27. Cox DR, Oates D: Analysis of Survival Data. Chapman and Hall, London/New York, 1984
28. Winger MJ, Macdonald DR, Cairncross JG: Supratentorial anaplastic gliomas in adult. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71: 487-493, 1989
29. Salminen E, Nuutinen JM, Huhtala S: Multivariate analysis of prognostic factors in 106 patients with malignant glioma. Eur J Cancer 32A(11): 1918-1923, 1996
30. Takanami I, Tanaka F, Hashizume T, Kodaira S: Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. Anticancer Res 17(4A): 2811-2814, 1997
31. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T: Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 15(2): 826-832, 1997
32. Relf M, LeJeune S, Scott PA, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R, Harris AL: Expression of the angionetic factors vascular endothelial growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet derived endothelial growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57(5): 963-969, 1997
33. Obermair A, Kucera E, Mayerhofer K, Speiser P, Seifert M, Czerwenka K, Kaider A, Leopolter S, Kainz C, Zeilinger R: Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free interval. Int J Cancer 74(4): 455-458, 1997
34. Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML: Vascular endothelial growth factor expression and vascular densitity as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 88(3): 513-520, 1998
35. Leon SP, Folkerth RD, Black PM: Microvessel density is a prognostic factor for patients with astroglial brain tumours. Cancer 77(2): 362-372, 1996
36. Shim JW, Koh YC, Ahn HK, Park YE, Hwang DY, Chi JG: Expression of bFGF and VEGF in brain astrocytoma. J Korean Med Sci 11(2): 149-157, 1996
37. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA: Vascular endothalial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 98(2): 548-553, 1998
38. Pepper MS, Mandriota SJ, Jeltsch M, Kumar V, Alitalo K: Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial extracellular proteolytic activity. J Cell Physiol 177(3): 439-452, 1998
39. Yamamoto S, Wakimoto H, Aoyagi M, Hirakawa K, Hamada H: Modulation of motility and proliferation of glioma cells by hepatocyte growth factor. JPN J Cancer Res 88(6): 564-577, 1997
40. Rosen EM, Lamszus K, Laterra J, Polverini PJ, Rubin JS, Goldberg ID: HGF/SF in angiogenesis. Ciba Found Symp 212: 215-226, 1997
41. Lamszus K, Schmidt NO, Westphal M: Angiogenic growth factors in human gliomas. (Abstract). J Neuro-Oncol 39(2): 121, 1998
42. Moriyama T, Kataoka H, Hamasuna R, Yokogami K, Uehara H, Kawano H, Goya T, Tsubouchi H, Koono M, Wakisaka S: Up-regulation of vascular endothelial growth factor induced by hepatocyte growth scatter factor stimulation in human gliomas cells. BBRC 249(1): 73-77, 1998
43. Newcomb EW, Cohen H, Lee SR, Bhalla SK, Bloom J, Hayes RL, Miller DC: Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. Brain Pathol 8: 655-667, 1998